Navigation Links
The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors
Date:10/22/2008

Dr. Polk is a world-renowned surgeon, researcher, administrator, and Chair Emeritus of the University of Louisville's Department of Surgery

WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) today announced its board of governors has unanimously elected Dr. Hiram C. Polk Jr. as chairman of the board. Dr. Polk succeeds the late Dr. Michael E. DeBakey, who was FBR's chairman for nearly 25 years.

"I am honored to represent the Foundation for Biomedical Research as its chairman," said Dr. Polk. "FBR has a unique and important goal: to educate the public about the necessity of research with animals for the future of human and animal health. I've been a surgeon for 40 years, so I know firsthand that the humane and responsible use of animal models in research is integral to the future of medical advancement and scientific discoveries."

For 34 years, Dr. Polk served as chair of the University of Louisville's Department of Surgery. During his tenure, he trained more than 230 general surgeons, more than any other surgery chair in the U.S., and transformed the university's surgical department into one of the nation's leading facilities. Polk's most significant contribution to medicine is his landmark research into the use of perioperative antibiotics. Additionally, Polk helped develop many current protocols for malignant melanoma treatments. Polk received his bachelor's degree from Millsaps College in Jackson, Mississippi, and his medical degree from Harvard Medical School in Cambridge, Massachusetts. Dr. Polk resides in Louisville, Kentucky, is prominent in the world of thoroughbred racing, and is a member of The Jockey Club.

FBR is honored to have the distinguished Dr. Polk serve as its chairman. For more information on FBR and Dr. Polk, please visit FBR's website at http://www.fbresearch.org.

Established in 1981, FBR is the nation's ol
'/>"/>

SOURCE Foundation for Biomedical Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The Champalimaud Foundation Invites Nominations and Applications for Its 2009 Vision Award
2. AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence
3. National Psoriasis Foundation Releases 2008 Study Results
4. World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center
5. Mens Health Network Welcomes its Newest Member to its Nationwide Team, The Sean Kimerling Testicular Cancer Foundation
6. Texas Health Resources Receives Grant From Robert Wood Johnson Foundation to Support Prevention of Family Violence
7. The National Kidney Foundation of the National Capital Areas 28th Annual Kidney Ball Featuring Entertainment by The Doobie Brothers
8. Ohio Dental Association Foundation Again Awards Over $60,000 in Dental Education Grants and Scholarships Across Ohio
9. Alzheimers Foundation of America Encourages Global Action on Awareness Raising
10. Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference
11. Partnership for Peak Healthcare Performance Receives Grant from Aetna Foundation to Improve Area Diabetes Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... 12, 2014 Ladies, it doesn't matter what ... Those who are looking for an affordable gown can ... occasion dresses) to get their dream items. Recently, the company ... length gowns . Along with that, it is also providing ... the special offer; the deadline of this promotion is July ...
(Date:7/11/2014)... According to new report "C4ISR ... expected to register a CAGR of 2.28% to ... market data tables and 76 figures spread through ... http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early buyers will receive ... , The report provides market analysis of the ...
(Date:7/11/2014)... -- Reducing the number of deer in an area ... other tick-borne infections among people, new research indicates. ... to reduce human interactions with deer, infected nymphal ticks ... wrote. White-tailed deer are the primary host for ... The study included nearly all the permanent residents ...
(Date:7/11/2014)... Microbiology testing is a highly dynamic and rapidly ... expected to pose the biggest challenge to suppliers in ... to the ongoing spread of AIDS – still the ... factor leading to the upsurge of opportunistic infections, novel ... availability of immunosuppressants, among others. , Market maturity, ...
(Date:7/11/2014)... Datalogic brings a new and innovative scanner ... With their new Gryphon GD4400 and GM4400 ... devastating MRSA, which claimed 5,500 lives, becomes more preventable. ... and the Gryphon GM4400-HC 2D readers can scan nearly ... barcodes off of troublesome LCD monitors, smartphones, and other ...
Breaking Medicine News(10 mins):Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3
... highly effective in preventing the behavioral and academic problems ... a five-year study led by researchers at Lehigh Universitys ... and funded by the National Institute of Mental Health ... children aged 3 to 5 who have shown significant ...
... Diabetes patients could benefit from new research at the ... the intestine that can taste the sugar content of ... receptor that senses sugar and artificial sweeteners is not ... intestine. The discovery will open new avenues for the ...
... misinformation onlineconsequences could be deadly , The Internet ... to spread false ideas about HIV/AIDS, which could have ... paper in PLoS Medicine. , "It may seem remarkable ... is still denial that the virus is the cause ...
... with organ transplants, resigned to a lifetime of anti-rejection ... respite, say researchers at Lucile Packard Children,s Hospital and ... blood sample, the scientists have identified for the first ... small group of patients who beat the odds and ...
... were more likely to be uninsured or covered by ... report in the August issue of Archives of Otolaryngology-Head ... Laryngeal [voice box] cancer is diagnosed in nearly 10,000 ... is among the most common cancers in the upper ...
... STANFORD, Calif. - As U.S. policy experts continue to ... a new study from the Stanford University School of ... group of patients reduce their overall risk of heart ... a cost-effective way. , Case management makes use of ...
Cached Medicine News:Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 2Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 3Health News:Discovery of 'sugar sensor' in intestine could benefit diabetes 2Health News:HIV denialists spread misinformation online -- consequences could be deadly; and more 2Health News:Study provides hope that some transplant patients could live free of anti-rejection drugs 2Health News:Study provides hope that some transplant patients could live free of anti-rejection drugs 3Health News:Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer 2Health News:Stanford study highlights cost-effective method of lowering heart disease risks 2Health News:Stanford study highlights cost-effective method of lowering heart disease risks 3
(Date:7/11/2014)... July 11, 2014 Research and Markets ... the "Immunoprotein Diagnostic Testing Market - Forecasts ... CAGR of 6% and is expected to be ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... testing has been segmented according to immunoprotein types ...
(Date:7/11/2014)... , July 11, 2014 ... visitors to Safety & Health Expo 2014 ... the move to London ... management attending exhibition.     ... http://photos.prnewswire.com/prnh/20140711/696892-a )      ...
(Date:7/10/2014)... India , July 11, 2014  Major ... treatment of cancer are being highlighted in a ... Mumbai from 10-12 July, 2014.  Renowned national ... to share best practices and exchange knowledge on ... precise, accurate and efficient. The ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... , SOUTH SAN FRANCISCO, Calif., July 8 Rigel Pharmaceuticals, ... Company plans to host a conference call on Thursday, July ... Members of Rigel,s senior management team and the principal investigator ... 2b TASKi2 clinical trial of R788 in rheumatoid arthritis, the ...
... OAKS, Calif., July 7 Amgen (Nasdaq: ... head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in ... advanced breast cancer met its primary and secondary endpoints ... was demonstrated for both delaying the time to the ...
Cached Medicine Technology:Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 2Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 2Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 3Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 4Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 5Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 6Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 7Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 8